WILMINGTON, Delaware, Feb. 23 -- AstraZeneca, a biopharmaceutical company, issued the following news release on Feb. 22, 2024: AstraZeneca today announced more than $3.3 million in financial contributions to 46 nonprofit organizations as part of its US Accelerate Change Together (ACT) on Health Equity: Community Solutions Challenge and National Strategic Collaborations. In its third year, ACT contributions are supporting US nonprofit programs aimed at improving conditions that affect community   more

WILMINGTON, Delaware, Feb. 20 -- AstraZeneca, a biopharmaceutical company, issued the following news release: AstraZeneca and Daiichi Sankyo's Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) who have received prior systemic therapy. The Prescription Drug User Fee Act date, the Food and Drug Administration (FDA) action date f  more

WILMINGTON, Delaware, Feb. 20 (TNSres) -- AstraZeneca, a biopharmaceutical company, issued the following news release: Positive high-level results from the LAURA Phase III trial showed AstraZeneca's TAGRISSO(R) (osimertinib) demonstrated a statistically significant and highly clinically meaningful improvement in progression-free survival (PFS) for patients with unresectable, Stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after chemoradiotherapy (CR  more

WILMINGTON, Delaware, Feb. 19 (TNSres) -- AstraZeneca, a biopharmaceutical company, issued the following news release: AstraZeneca's TAGRISSO(R) (osimertinib) with the addition of chemotherapy has been approved in the US for the treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). The approval following a Priority Review by the Food and Drug Administration (FDA) was based on the results from the FLA  more

DOVER, Delaware, Feb. 21 -- Delaware Attorney General Kathy Jennings issued the following opinion (No. 24-IB09) on Feb, 19, 2024: * * * To: Xerxes Wilson, xwilson@delawareonline.com RE: FOIA Petition Regarding the Delaware Department of Correction Dear Mr. Wilson: We write regarding your correspondence alleging that the Delaware Department of Correction ("DOC") violated the Delaware Freedom of Information Act, 29 Del. C. Sec.Sec. 10001-10008 ("FOIA"). We treat your correspondence as a Petit  more

DOVER, Delaware, Feb. 24 -- Delaware Attorney General Kathy Jennings issued the following opinion (No. 24-IB11) on Feb. 23, 2024: * * * To: Isabel Hughes, ihughes@delawareonline.com RE: FOIA Petition Regarding the Division of Delaware State Police of the Department of Safety and Homeland Security Dear Ms. Hughes: We write regarding your correspondence alleging that the Division of Delaware State Police of the Department of Safety and Homeland Security ("DSP") violated the Delaware Freedom of  more

DOVER, Delaware, Feb. 23 -- Delaware Attorney General Kathy Jennings issued the following news release on Feb. 22, 2024: Attorney General Kathy Jennings today co-led a coalition of 18 attorneys general filing an amicus brief with the U.S. Court of Appeals for the 3rd Circuit. The coalition urged the court to revisit an opinion striking down a Pennsylvania law prohibiting individuals under the age of 21 from carrying concealed weapons in public and imposing additional restrictions during declare  more

DOVER, Delaware, Feb. 24 -- Delaware Department of Natural Resources and Environmental Control issued the following news on Feb. 23, 2024: The Delaware Department of Natural Resources and Environmental Control will host a free webinar Wednesday, Feb. 28 to introduce property owners to DNREC's Living Shoreline Cost Share Program, which provides funding that can help Delawareans in selected watersheds install living shorelines using natural materials. The hour-long webinar begins at 10 a.m. and r  more

NEWARK, Delaware, Feb. 20 -- Delmarva Power, a subsidiary of Exelon, issued the following news release: Delmarva Power customers can now request a free tree to plant at their home as part of the company's partnership with the Arbor Day Foundation's Energy-Saving Trees program. Residential customers can reserve a complimentary tree on a first-come, first-served basis and reap the energy-saving benefits that trees provide. Delmarva Power will make 600 free trees available to customers throughout  more

DELAWARE, Ohio, Feb. 20 -- Ohio Wesleyan University issued the following news release: Ohio Wesleyan University will host a free panel discussion at 9 a.m. Feb. 29 to explore "Improving Water Quality in Ohio: Efficient Policies and Local Programs." The event will include a moderated discussion between the panelists and questions from the audience. The Environmental and Natural Resource Symposium will be held in Room 301 of Merrick Hall, 65 S. Sandusky St., Delaware. The event is sponsored by T  more

LOS ANGELES, California, Feb. 24 -- Paul Hastings, a law firm, issued the following news: Paul Hastings LLP has been selected as counsel to the Official Committee of Unsecured Creditors of Cano Health, Inc. and its affiliated debtors that have filed chapter 11 cases in the United States Bankruptcy Court for the District of Delaware. Cano Health is one of the largest independent primary care physician groups in the U.S. Kris Hansen and Erez Gilad will lead the team. * * * Original text here:  more

SYDNEY, Australia, Feb. 21 -- Squire Patton Boggs, a law firm, issued the following news: Squire Patton Boggs has advised Tamboran Resources Corporation (Tamboran, ASX:TBN) on a 'market-first' succession of transactions. The transactions include its 'Top-hat' scheme of arrangement in the Federal Court involving the re-domiciliation of Tamboran Resources Limited and its subsidiaries (Tamboran Group) to the US by superimposing a newly incorporated entity (Tamboran Resources Corporation) in the St  more